Aragen Bioscience Announces Licensing Agreement for Protein Production Technology from ProteoNic Biotechnology
Aragen Bioscience, Inc. (Aragen) announces that it has entered into an agreement with ProteoNic Biotechnology BV (ProteoNic) for the commercial use of ProteoNic’s 2G UNic™ recombinant protein production technology. The technology has been demonstrated to be broadly applicable to various protein targets, multiple host cell lines as well as selection systems. <MORE
BioProcess International Conference
Booth # 1017
We are excited for this year’s BioProcess International Conference in Boston. Discover how Aragen Bioscience can transform the way you do research by visiting us at Booth 1017 for a discussion with our team about our newest service offerings.